Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Open in API
Filings indexed 638 across all filing types
Latest filing 2022-11-08 Regulatory Filings
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-11-08 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-11-08 English
News release - English.pdf
Call Transcript Classification · 90% confidence The document is a press release announcing a scheduled conference call to discuss Medexus Pharmaceuticals' second quarter 2023 financial results. It mentions the date and time of the call, how to participate, and that the financial statements and MD&A will be filed after market close. The document does not contain actual financial data or detailed financial analysis but serves as an announcement for the upcoming earnings call. Therefore, it is not the earnings release itself but a notice about the call. The appropriate classification for this type of document is a Call Transcript (CT) category, as it relates to the conference call event. However, since this is only an announcement of the call and not the transcript, the best fit is still Call Transcript (CT) because the document is specifically about the earnings call event. Confidence is high due to clear references to the conference call and earnings discussion.
2022-11-02 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing preliminary revenue results for the second fiscal quarter 2023, including expected revenue figures and business highlights. It does not contain detailed financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR). The document is longer than 5,000 characters but primarily serves as an earnings preview or update rather than a full report. It is not a full earnings release (ER) since it provides preliminary estimates rather than finalized results. The content fits best as a Capital/Financing Update (CAP) because it discusses revenue expectations, business performance, and liquidity position, which are typical of financing or capital-related updates. Therefore, the classification is CAP with high confidence.
2022-10-06 English
News release - English.pdf
Regulatory Filings
2022-09-29 English
Report of voting results.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'Report of Voting Results for Annual Meeting of Shareholders on September 15, 2022' and details the voting outcomes on various shareholder meeting matters such as election of directors, appointment of auditors, and approval of a new long-term incentive plan. It references the management information circular dated August 5, 2022, but the document itself is focused on reporting the official voting results from the annual meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 3736 characters, which is consistent with a detailed voting results report rather than a brief announcement or a full annual report. Therefore, the correct classification is DVA with high confidence.
2022-09-21 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.